The Clic Team
We support your journey to translation
Dr. Garima Bhardwaj
Head of the BIH Clinical Incubator (CLIC)
Dr. Garima Bhardwaj is the Head of the BIH Clinical Incubator at the Berlin Institute of Health (BIH), where she leads efforts to bridge the gap between cutting-edge biomedical research and real-world clinical applications. Garima oversees the day-to-day operations of the incubator, collaborating with local stakeholders, managing a multidisciplinary team, and fostering an innovative ecosystem to accelerate the commercialization of novel therapies. Her work is centered on supporting life science entrepreneurs and driving advancements in personalized and regenerative medicine.
Dr. Franka Klatte-Schulz
Science Operations Manager
Dr. Franka Klatte-Schulz is the Science Operations Manager at the BIH Clinical Incubator. She oversees the co-working laboratory environment, ensuring smooth scientific operations, regulatory compliance, and access to state-of-the-art research infrastructure. Franka also coordinates scientific workshops and community events, fostering collaboration and knowledge exchange. As a key contact for CLIC residents, she provides scientific guidance and connects teams with researchers, experts, and core facilities across the Charité and BIH ecosystem. Her goal is to create a collaborative environment that helps teams turn innovative ideas into successful products.
Gady Goldsobel
Liaison for Pre-Incubation
Gady identifies early-stage academic projects with strong innovation potential and helps position them for success within the CLIC program. He supports teams through key aspects of early development - including grant strategy, intellectual property readiness, and contracting - and coordinates pre-incubation activities. Once teams are fully prepared, he transitions them for onboarding and evaluation within the incubator.
Nicole Bormann
Lab Manager
Nicole Bormann serves as the Lab Manager at CLIC. In her role, she provides comprehensive support and coordination for laboratory operations, ensuring smooth processes and the well-being of all laboratory personnel. Her responsibilities include overseeing laboratory safety in compliance with BioStoffV, GenTV, and GefStoffV regulations, as well as managing essential tasks such as developing operating instructions, maintaining the hazardous substances register, conducting risk assessments, and ensuring proper equipment maintenance. Nicole also handles inventory management, including materials and reagents, and oversees purchasing of new supplies.
Maja Pizevska
Clinical Development and Regulatory Affairs Specialist
As part of the BIH Clinical Incubator at Charité, Maja leverages her extensive expertise to bridge the gap between pioneering biomedical research and real-world clinical applications, with a special focus on cell and gene therapies. With five years of experience in regulatory affairs and clinical development, she plays a crucial role in assisting research teams and principal investigators in setting up early-phase clinical studies. Her guidance on regulatory pathways and interactions with authorities ensures that groundbreaking therapies transition smoothly from concept to clinical trials.
Enrico Fritsche
Clinical Development and Regulatory Affairs Specialist
As part of the BIH Clinical Incubator at Charité, and with nine years of experience in regulatory affairs and clinical development, Enrico supports clinical research teams in setting up early-phase clinical trials (Phase I/IIa), with a focus on cell and gene therapies. His responsibilities also include preparing and submitting clinical trial dossiers in CTIS, registration of investigational medicinal products in European databases, as well as interactions with national and European regulatory bodies regarding regulatory procedures (e.g. approvals, RFIs, Scientific Advice formats). He also contributes to Regulatory Science in various EMA platforms. In addition, he is responsible for internal project management, support for manufacturing authorization applications, GMO-related regulatory affairs and approval procedures, as well as ongoing monitoring and support of already approved clinical trials in CTIS.
Constanze Gerhards
Project Controlling and Financial Management
Constanze Gerhards oversees Project Controlling and Financial Management at the BIH Clinical Incubator. In this role, she supports the incubator's development by managing a wide range of administrative tasks, with a particular focus on financial matters and personnel management.
Prof. Georg Duda
Director of the Julius Wolff Institute, Spokesperson for the Berlin Center for Regenerative Therapies
Prof. Georg Duda brings extensive expertise in translational medicine and regenerative therapies to guide the strategic development of the program. As Director of the Julius Wolff Institute and spokesperson for the BIH Center for Regenerative Therapies, he has a proven track record of advancing innovative therapies toward clinical application.
With a strong focus on bridging basic research and patient care, Prof. Georg Duda supports the incubator's mission to establish effective structures for biomedical translation and foster an environment where novel therapeutic approaches can be developed, de-risked, and advanced toward clinical implementation.
Prof. Ludovic Vallier
Einstein Strategic Professorship for Stem Cells in Regenerative Therapies
Prof. Ludovic Vallier brings expertise in stem cell biology, regenerative medicine, and the development of advanced therapeutic approaches. As a leading researcher in the field, he has extensive experience translating fundamental scientific discoveries into innovative strategies for disease modeling and cell-based therapies.
With a strong focus on human biology and clinical relevance, Prof. Ludovic Vallier supports the incubator's mission to accelerate biomedical innovation and enable the development of novel therapies from early-stage research to clinical application.
Dr. Johannes Fruehauf
CEO & Founder of BioLabs and LabCentral, General Partner at Mission BioCapital
Dr. Johannes Fruehauf brings extensive experience in biotechnology, entrepreneurship, and the translation of innovative therapies into clinical development. As a physician-scientist and industry leader, he has a strong track record of founding and scaling successful life science companies while advancing novel therapeutic approaches toward commercialization.
With deep expertise at the interface of science, medicine, and business, Dr. Johannes Frühauf supports the incubator's mission to accelerate the development of cutting-edge biomedical innovations and guide projects from early discovery through clinical translation.
Dr. Andreas Hüser
CEO & Co-Founder CheckImmune
Dr. Andreas Hüser brings extensive experience in healthcare innovation, technology transfer, and the strategic development of biomedical programs. With a strong background in fostering collaborations between academia, industry, and clinical partners, he has played a key role in advancing translational research and implementing innovative healthcare solutions.
With deep expertise in innovation management and funding strategies, Dr. Andreas Hüser supports the incubator's mission to accelerate the translation of scientific discoveries into clinical applications and create sustainable pathways for bringing novel therapies to patients.
BioLabs – Advancing Innovation Worldwide
At the heart of CLIC's offering is its partnership with BioLabs, a global leader in the management of life science incubators. This collaboration enables CLIC to provide world-class infrastructure and services while drawing on BioLabs' extensive experience in supporting life science start-ups around the world. Through this partnership, CLIC connects its resident teams to BioLabs' international network, providing unparalleled access to resources, expertise, and capital.
BioLabs has a proven track record of fostering successful biotechnology companies. In its first year of operations in Europe alone, BioLabs supported more than 55 start-ups, and since its founding, companies within the BioLabs network have raised more than €6.5 billion. By leveraging this global ecosystem, CLIC ensures that entrepreneurs in Berlin benefit from an outstanding environment for growth, innovation, and successful translation.